This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Biocon Biologics announced the successful results of a pivotal Phase 3, randomised, double-blind, parallel group, multicenter study comparing Yesintek (Biocon Biologics biosimilar to Ustekinumab, called YESINTEK) with reference product Stelara (Ustekinumab) in adult patients with moderate to severe chronic plaque psoriasis (PsO). The data are being presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting in Orlando, Florida.
In this article a clinical infectious diseases pharmacist reviews five things for pharmacists to know about measles in 2025. Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP – – POST UNDER CONSTRUCTION – – Article posted 8 March 2025 This week on Tuesday night a few text messages came through on WhatsApp chats about how there was a measles case from a high school student here in the Miami area.
A paper published by the Drug Safety Research Unit (DSRU) in the British Journal for Clinical Pharmacology , has asserted the need for ongoing assessment of the safety and effectiveness of the Alzheimers drug lecanemab in the real-world clinical setting. The Medicines and Healthcare products Regulatory Agency (MHRA) approved the drug for use in the UK in August 2024.
In 2023, ReNAgade Therapeutics launched with $300 million to exploit an “all in one” technology solution for RNA-based therapies. That same year, Tome Biosciences emerged from stealth with $213 million to develop new gene editors, and Aera Therapeutics launched with $193 million to solve the delivery challenge for gene therapies. By the end of 2024, ReNAgade employees had faced multiple rounds of layoffs including through a corporate merger, Tome had abruptly gone from 130 employee
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
We are exposed to so many toxins every day both inside and outside our homes (some are obvious, some less so). For those of us with Hashimotos, this toxin overload can be particularly problematic, as our bodies often struggle to eliminate toxins efficiently. [1] This inability to detox properly can trigger or worsen autoimmune symptoms, as these chemical exposures can trigger immune dysregulation. [2] This is why we need to be especially diligent when it comes to addressing chemical exposure in
UnitedHealth Group, the largest health care company in the U.S., has clear ambitions of getting bigger. The sprawling conglomerate — which owns a major health insurance company, physician practices, a pharmacy benefit manager, and numerous other firms — acquired or created more than 250 subsidiaries in 2024. Pretty much all of those deals weren’t publicly announced, since the transactions are small relative to UnitedHealth’s size.
Todays guest post is from Divya Iyer, SVP Go-to-Market (GTM) Strategy at GoodRx. Divya argues that patient support programs (PSPs) struggle with awareness and accessibility, preventing patients from fully benefiting from the financial and educational resources available to them. Divya discusses how integrating digital solutions from GoodRx can enhance engagement, streamline access to therapy, and improve patient outcomes.
93
93
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Todays guest post is from Divya Iyer, SVP Go-to-Market (GTM) Strategy at GoodRx. Divya argues that patient support programs (PSPs) struggle with awareness and accessibility, preventing patients from fully benefiting from the financial and educational resources available to them. Divya discusses how integrating digital solutions from GoodRx can enhance engagement, streamline access to therapy, and improve patient outcomes.
In an unprecedented move, the National Institutes of Health is abruptly terminating millions of dollars in research awards to scientists in Massachusetts and around the country, citing the Trump administration’s new restrictions on funding anything related to diversity, equity, and inclusion, transgender issues, or research that could potentially benefit universities in China.
Click below to read ASBM member WeWorkForHealth’s Fact Sheet on the effects of the IRA’s “Pill Penalty”, also known as the “Small-Molecule Penalty”, which disincentivizes R&D on chemically-derived medicines used to treat many serious conditions like cancer and heart disease: Click below to view
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Eight years after the March for Science galvanized more than 1 million people globally, scientists will be back in the streets Friday to “Stand Up for Science.” We’ll be there, too, reporting on the gatherings in Boston, NYC and D.C.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
After yet another record year for health data breaches, updated federal security rules to protect patient information are on the table in 2025. Patients and providers have long complained that HIPAA, or the Health Insurance Portability and Accountability Act, is ill-suited to protect patients’ sensitive health data in the digital age — and in January, the Department of Health and Human Services proposed updated regulations to protect against the growing threat of cyberattacks.
FOR IMMEDIATE RELEASE March 7, 2025 Arlington, VA The Alliance for Safe Biologic Medicines (ASBM) today expressed its support and gratitude to Senators Thom Tillis (R-NC), Ted Budd (R-NC), Marsha Blackburn (R-TN), James Lankford (R-OK), and Steve Daines (R-MT) for their leadership in introducing the Ensuring Pathways to Innovative Cures (EPIC) Act (S. 832) March 4 th.
A happy Friday to you from STAT’s London outpost, ending a week in which the sun decided to finally come back after a few gloomy months. But we here in the U.K. are jealous of those of you in the U.S. with your impending Spring Forward this weekend, as we have to wait another three weeks before we move our clocks ahead. Oh well, nothing another cup of stimulation (or perhaps a pint at the pub) can’t fix.
The Swiss pharma will base cardiometabolic drug research at the new Allston site. Elsewhere, AskBio advanced a gene therapy and Pfizer hired a scientist well versed in GLP-1 science.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
David Page’s bio reads like a history of science in the age of genomics. In 1979 he was the first student to work on what we now know as the Human Genome Project. He then became a fellow at the Whitehead Institute for Biomedical Research before joining its faculty (and MIT’s), and later served as Whitehead’s president for 16 years.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hi there. Today, we unpack Marty Makary’s Senate confirmation hearing, see a new ruling against GLP-1 compounders, examine the effects of the NIH patent freeze, and explore the tumultuous biotech job market.
The NHS could prevent thousands more heart attacks and strokes every year by offering everyone in the UK aged 50 and over a single "polypill" combining a statin and three blood pressure lowering drugs, according to academics from UCL. In an opinion piece for The BMJ, the authors argued that a polypill programme could be a "flagship strategy" in Labour's commitment to preventing disease rather than treating sickness.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Kirthana M V Sindhe, Senior Commercial Marketing Manager, Merck As women scientists in R&D, our journey has been one of passion, perseverance, and resilience. While we have made significant contributions to drug discovery, clinical research, and innovation, the road has not always been easy. Here are some key challenges I have facedand how I tackled them.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
The struggling retail pharmacy chain entered an agreement to be purchased by private equity firm Sycamore Partners, which could end its nearly 100-year run as a public company.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
I know what its like to feel completely drained by your pharmacy job, to feel like every shift chips away at whatever passion you once had. It starts as frustration, then exhaustion, then full-blown burnout. And the worst part? It doesnt just stay at work. It follows you home. It poisons your weekends, your relationships, your mental health. It turns patients into problems.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
52 
Let's personalize your content